Items where Funder is F. Hoffman La Roche Ltd.

BO20289

Bell, R, Brown, JM orcid.org/0000-0002-2719-7064, Parmar, M et al. (18 more authors) (2017) Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer. Annals of Oncology, 28 (4). pp. 754-760. ISSN 0923-7534

MR/N011775/1

Pujades-Roderiguez, M, Morgan, AW orcid.org/0000-0003-1109-624X, Cubbon, RM orcid.org/0000-0001-7844-3600 et al. (1 more author) (2020) Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLoS Medicine, 17 (12). e1003432. ISSN 1549-1277

WA40984

Pujades-Roderiguez, M, Morgan, AW orcid.org/0000-0003-1109-624X, Cubbon, RM orcid.org/0000-0001-7844-3600 et al. (1 more author) (2020) Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLoS Medicine, 17 (12). e1003432. ISSN 1549-1277